Crispr Therapeutics
CRSPInsider trades and stock quote 2024-2026
All insider trades at Crispr Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 3/23/2026 | Sell | Prasad, Raju | Chief Financial Officer | $46.8 | $173,460 |
| 3/23/2026 | Sell | Kulkarni, Samarth | Chief Executive Officer | $46.8 | $468,736 |
| 3/23/2026 | Sell | Kasinger, James R. | General Counsel and Secretary | $46.8 | $148,854 |
| 3/16/2026 | Sell | Kulkarni, Samarth | Chief Executive Officer | $48.3 | $499,443 |
| 3/16/2026 | Sell | Kasinger, James R. | General Counsel and Secretary | $48.3 | $166,497 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)